BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hsu CYM, Walsh T, Borys BS, Kallos MS, Rancourt DE. An Integrated Approach toward the Biomanufacturing of Engineered Cell Therapy Products in a Stirred-Suspension Bioreactor. Mol Ther Methods Clin Dev 2018;9:376-89. [PMID: 30038941 DOI: 10.1016/j.omtm.2018.04.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Nath SC, Harper L, Rancourt DE. Cell-Based Therapy Manufacturing in Stirred Suspension Bioreactor: Thoughts for cGMP Compliance. Front Bioeng Biotechnol 2020;8:599674. [PMID: 33324625 DOI: 10.3389/fbioe.2020.599674] [Reference Citation Analysis]
2 Gong L, Petchakup C, Shi P, Tan PL, Tan LP, Tay CY, Hou HW. Direct and Label-Free Cell Status Monitoring of Spheroids and Microcarriers Using Microfluidic Impedance Cytometry. Small 2021;17:e2007500. [PMID: 33759381 DOI: 10.1002/smll.202007500] [Reference Citation Analysis]
3 Neto MD, Oliveira MB, Mano JF. Microparticles in Contact with Cells: From Carriers to Multifunctional Tissue Modulators. Trends Biotechnol 2019;37:1011-28. [PMID: 30902347 DOI: 10.1016/j.tibtech.2019.02.008] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 11.3] [Reference Citation Analysis]
4 Kucharski M, Mrowiec P, Ocłoń E. Current standards and pitfalls associated with the transfection of primary fibroblast cells. Biotechnol Prog 2021;37:e3152. [PMID: 33774920 DOI: 10.1002/btpr.3152] [Reference Citation Analysis]